- Home
- YPF vs ITCI Comparison
YPF vs ITCI Comparison
Compare YPF & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YPF
- ITCI
- Stock Information
- Founded
- YPF 1977
- ITCI 2002
- Country
- YPF Argentina
- ITCI United States
- Employees
- YPF N/A
- ITCI N/A
- Industry
- YPF Integrated oil Companies
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- YPF Energy
- ITCI Health Care
- Exchange
- YPF Nasdaq
- ITCI Nasdaq
- Market Cap
- YPF 8.5B
- ITCI 8.0B
- IPO Year
- YPF 1993
- ITCI N/A
- Fundamental
- Price
- YPF $23.41
- ITCI $76.40
- Analyst Decision
- YPF Buy
- ITCI Strong Buy
- Analyst Count
- YPF 6
- ITCI 11
- Target Price
- YPF $24.77
- ITCI $93.55
- AVG Volume (30 Days)
- YPF 1.6M
- ITCI 472.1K
- Earning Date
- YPF 11-06-2024
- ITCI 10-31-2024
- Dividend Yield
- YPF N/A
- ITCI N/A
- EPS Growth
- YPF N/A
- ITCI N/A
- EPS
- YPF N/A
- ITCI N/A
- Revenue
- YPF $12,740,742,293.00
- ITCI $564,526,000.00
- Revenue This Year
- YPF $225.73
- ITCI $46.60
- Revenue Next Year
- YPF $3.03
- ITCI $37.06
- P/E Ratio
- YPF N/A
- ITCI N/A
- Revenue Growth
- YPF 243.15
- ITCI 54.31
- 52 Week Low
- YPF $9.57
- ITCI $45.50
- 52 Week High
- YPF $24.77
- ITCI $84.89
- Technical
- Relative Strength Index (RSI)
- YPF 61.29
- ITCI 55.99
- Support Level
- YPF $22.11
- ITCI $73.05
- Resistance Level
- YPF $23.38
- ITCI $76.34
- Average True Range (ATR)
- YPF 0.77
- ITCI 1.64
- MACD
- YPF -0.01
- ITCI 0.27
- Stochastic Oscillator
- YPF 64.03
- ITCI 86.44
About YPF YPF Sociedad Anonima
YPF SA is an Argentina-based integrated oil and gas company. It is engaged in operating a fully integrated oil and gas chain across the domestic upstream, downstream, and gas and power segments. The company's upstream operations consist of the exploration, development, and production of crude oil, natural gas, and LPG. Its downstream operations include the refining, marketing, transportation, and distribution of oil and a wide range of petroleum products, petroleum derivatives, petrochemicals, LPG, and bio-fuels. The company generates maximum revenue from the downstream segment.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.